PUBLISHER: Market Research Future | PRODUCT CODE: 1481363

PUBLISHER: Market Research Future | PRODUCT CODE: 1481363

India HbA1c Market Research Report Forecast to 2032

PUBLISHED: May 5, 2024

PAGES: 86 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

India HbA1c Market is anticipated to register a CAGR of 8.49% during the review period. HbA1c testing is a blood test that measures the average level of blood sugar over the past two to three months. It is also known as glycated haemoglobin or A1C. This test is important for people with diabetes because it provides a more comprehensive view of blood sugar control than regular fingerstick tests, which only measure blood sugar levels at specific times.

The rising prevalence of type 2 diabetes and the increased prevalence of thalassemia and sickle cell disease coupled with growing awareness among Indians are major factors driving the growth of the India HbA1c testing market. However, the high cost of HbA1c testing due to technological advancements and frequent utilization of kits and reagents is expected to hamper the growth of the Indian market. Nevertheless, the growing geriatric population is anticipated to create lucrative opportunities for the players operating in the Indian market.

Market Segmentation

On the basis of product type, the India HbA1c testing market has been segmented into reagents & kits, instruments. Instruments were further segmented into bench top devices, and hand-held devices.

Based on technology, the market has been segmented into ion-exchange HPLC, immunoassay, boronate affinity HPLC, enzymatic assay, turbidimetric inhibition immunoassay (TINIA), and others.

Based on application, the market has been segmented into thalassemia, sickle cell anemia, and type 2 diabetes.

Based on end user, the market has been segmented into hospitals and clinics, diagnostic laboratories, and others.

Major Players

The key market players are Siemens Healthineers AG, Abbott, F. Hoffmann-La Roche Ltd, LumiraDx, Bio-Rad Laboratories, Inc., ARKRAY, Inc., Beckman Coulter Inc., LumiraDx, and Transasia Bio-Medicals.

1 MARKET INTRODUCTION

1.1 DEFINITION
1.2 SCOPE OF THE STUDY
1.3 RESEARCH OBJECTIVE
1.4 MARKET STRUCTURE

2 RESEARCH METHODOLOGY

2.1 OVERVIEW
2.2 DATA FLOW
- 2.2.1 Data Mining Process
2.3 PURCHASED DATABASE:
2.4 SECONDARY SOURCES:
- 2.4.1 Secondary Research data flow:
2.5 PRIMARY RESEARCH:
- 2.5.1 Primary Research DATA FLOW:
- 2.5.2 Primary Research: Number of Interviews conducted
2.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 2.6.1 Revenue Analysis Approach
2.7 DATA FORECASTING
- 2.7.1 Data forecasting Technique
2.8 DATA MODELLING
- 2.8.1 microeconomic factor analysis:
- 2.8.2 Data moldelling:
2.9 TEAMS AND ANALYST CONTRIBUTION

3 MARKET DYNAMICS

3.1 INTRODUCTION
3.2 DRIVERS
- 3.2.1 Rising Prevalence of Type diabetes32
- 3.2.2 Increased prevalence of Thalassemia and Sickle CELL among india
3.3 RESTRAINTS
- 3.3.1 High Cost of HbA1c Testing
3.4 OPPORTUNITY
- 3.4.1 Growing geriatric population

4 MARKET FACTOR ANALYSIS

4.1 PORTER'S FIVE FORCES MODEL
- 4.1.1 Threat of New Entrants
- 4.1.2 BARGAINING POWER OF SUPPLIERS
- 4.1.3 Threat of Substitutes
- 4.1.4 Bargaining Power of Buyers
- 4.1.5 Intensity of Rivalry
4.2 IMPACT OF COVID-19 ON THE INDIA HBA1C TESTING MARKET
4.3 REGULATORY LANDSCAPE BY INDIA
4.4 QUALITATIVE DATA ON NEW MEDTECH POLICES IN INDIA
4.5 OVERVIEW ON ISSUES EXPECTED FOR MAKE IN INDIA POLICES FORM TENDERS
4.6 CURRENT TRENDS IN THE INDIA HBA1C TESTING MARKET
4.7 QUALITATIVE DATA ON OPPORTUNITY FOR SELLING DIAGNOSTICS EQUIPMENTS FOR THE CLIENTS

5 INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE

5.1 OVERVIEW
5.2 INSTRUMENTS

6 INDIA HBA1C TESTING MARKET, BY TECHNOLOGY

6.1 OVERVIEW

7 INDIA HBA1C TESTING MARKET, BY APPLICATION

7.1 OVERVIEW

8 INDIA HBA1C TESTING MARKET, BY END USER

8.1 OVERVIEW

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 MARKET SHARE ANALYSIS,57
9.3 COMPETITOR DASHBOARD
9.4 PUBLIC PLAYERS STOCK SUMMARY
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 9.6.1 product launch
- 9.6.2 Collaboration

10 COMPANY PROFILES

10.1 SIEMENS HEALTHINEERS AG
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 productS OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
10.2 PTS DIAGNOSTICS
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 products OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 KEY STRATEGIES
10.3 ARKRAY, INC
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 productS OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 KEY STRATEGIES
10.4 F. HOFFMANN-LA ROCHE LTD
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 SWOT ANALYSIS
- 10.4.6 KEY STRATEGIES
10.5 BECKMAN COULTER, INC.
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 Products OFFERed
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 SWOT ANALYSIS
- 10.5.6 KEY STRATEGIES
10.6 LUMIRADX
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 Products OFFERed
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 KEY STRATEGIES
10.7 ABBOTT
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 PRODUCTS OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 SWOT ANALYSIS
- 10.7.6 KEY STRATEGIES
10.8 BIO-RAD LABORATORIES, INC.
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 PRODUCTS OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 SWOT ANALYSIS
- 10.8.6 KEY STRATEGIES
10.9 TRANSASIA BIO-MEDICALS
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 PRODUCTS OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 KEY STRATEGIES
10.10 HEMOCUE AB
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 Products OFFERed
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES

11 DATA CITATIONS

LIST OF TABLES

TABLE 1 QFD MOLDELLING FOR MARKET SHARE ASSESSMENT
TABLE 2 REGULATORY LANDSCAPE BY INDIA
TABLE 3 INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
TABLE 4 INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (UNITS)
TABLE 5 INDIA HBA1C TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 6 INDIA HBA1C TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2019-2032 (UNITS)
TABLE 7 INDIA HBA1C TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
TABLE 8 INDIA HBA1C TESTING MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 9 INDIA HBA1C TESTING MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 10 INDIA HBA1C TESTING MARKET, FOR HOSPITALS, BY PRODUCT TYPE, 2019-2032 (UNITS)
TABLE 11 INDIA HBA1C TESTING MARKET, FOR GOVERNMENT HOSPITALS, BY PRODUCT TYPE, 2019-2032 (UNITS)
TABLE 12 INDIA HBA1C TESTING MARKET, FOR PRIVATE HOSPITALS, BY PRODUCT TYPE, 2019-2032 (UNITS)
TABLE 13 PUBLIC PLAYERS STOCK SUMMARY
TABLE 14 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 15 PRODUCT LAUNCH
TABLE 16 COLLABORATION
TABLE 17 SIEMENS HEALTHINEERS AG: PRODUCT OFFERED
TABLE 18 PTS DIAGNOSTICS: PRODUCT OFFERED
TABLE 19 PTS DIAGNOSTICS: KEY DEVELOPMENTS
TABLE 20 ARKRAY, INCPRODUCT OFFERED
TABLE 21 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED
TABLE 22 BECKMAN COULTER INC.: PRODUCTS OFFERED
TABLE 23 LUMIRADX: PRODUCTS OFFERED
TABLE 24 ABBOTT: PRODUCTS OFFERED
TABLE 25 ABBOTT: KEY DEVELOPMENTS
TABLE 26 BIO-RAD LABORATORIES, INC.: PRODCUTS OFFERED
TABLE 27 TRANSASIA BIO-MEDICALS: PRODUCTS OFFERED
TABLE 28 HEMOCUE AB: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1INDIA HBA1C TESTING MARKET: STRUCTURE
FIGURE 2INDIA HBA1C MARKET REPORT: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
FIGURE 3DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5PORTER'S FIVE FORCES ANALYSIS: INDIA HBA1C TESTING MARKET
FIGURE 6INDIA HBA1C TESTING MARKET, PRODUCT TYPE SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION)
FIGURE 7INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE, 2022 & 2032 (USD MILLION)
FIGURE 8INDIA HBA1C TESTING MARKET SHARE (%), BY PRODUCT TYPE, 2022
FIGURE 9INDIA HBA1C TESTING MARKET, TECHNOLOGY SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION)
FIGURE 10INDIA HBA1C TESTING MARKET, BY TECHNOLOGY, 2022 & 2032 (USD MILLION)
FIGURE 11INDIA HBA1C TESTING MARKET SHARE (%), BY TECHNOLOGY, 2022
FIGURE 12INDIA HBA1C TESTING MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION)
FIGURE 13INDIA HBA1C TESTING MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION)
FIGURE 14INDIA HBA1C TESTING MARKET SHARE (%), BY APPLICATION, 2022
FIGURE 15INDIA HBA1C TESTING MARKET, END USER SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION)
FIGURE 16INDIA HBA1C TESTING MARKET, BY END USER, 2022 & 2032 (USD MILLION)
FIGURE 17INDIA HBA1C TESTING MARKET SHARE (%), BY END USER, 2022
FIGURE 18INDIA HBA1C TESTING MARKET PLAYERS: COMPETITIVE ANALSIS, 2022
FIGURE 19COMPETITOR DASHBOARD: INDIA HBA1C TESTING MARKET
FIGURE 20SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21SIEMENS HEALTHINEERS AG: SWOT ANALYSIS
FIGURE 22F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 24BECKMAN COULTER INC.: SWOT ANALYSIS
FIGURE 25LUMIRADX: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26ABBOTT: FINANCIAL OVERVIEW
FIGURE 27ABBOTT: SWOT ANALYSIS
FIGURE 28BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW
FIGURE 29BIO-RAD LABORATORIES, INC: SWOT ANALYSIS

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ